|
COPYRIGHT 2005 Investor's Business Daily, Inc.
MEDICAL
AstraZeneca reports, ups views
The drug maker earned $1.23 bil in Q3 vs. $1.14 bil a year ago. Views weren't available. Sales rose to $5.8 bil from $5.6 bil. AstraZeneca hiked its '05 outlook to $2.85-$2.95 a share from its previous $2.75. It's fighting a patent challenge from Teva Pharma for...
Read the full article for free courtesy of your local library.
|